JKJosef Korinek

Josef Korinek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Josef Korinek has a total of 196 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Decrease in longitudinal strain in heart transplant recipients is associated with rejection

    by Helena Podrouzkova, Helena Bedanova, Martin Tretina, Josef Korinek, Radka Stepanova, Jana Hruskova, Petr Nemec, Tomas Konecny, Marek Orban

    Around 20-40% of heart transplant patients experience moderate to severe rejection within the first year after heart transplantation. Endomyocardial biopsy (EMB) is a gold standard for diagnosing heart transplant rejection. There is a need for non-invasive alternatives that allow for early, safe and reliable diagnosis of acute graft rejection prior to the onset of clinical symptoms. Our aim was to investigate the potential of speckle tracking derived strain analysis in the diagnosis of acute graft rejection. Patients indicated for EMB consented to a trans-thoracic echocardiography examination (TTE) within 2 hours of the EMB. Of this cohort, those with at least 2 EMBs separated ≥ 1 week, and whose TTE could be analyzed for strain, were included. The relationship between strain and EMB results was evaluated. Of the 43 patients included (mean age 51.33±1.79, 67% male), 23 had findings of rejection identified on at least one EMB and at least one EMB without rejection for comparison. A significant deterioration in the longitudinal strain during rejection compared to non-rejection was found on apical 4-chamber views (-11.51±0.91 vs -13.48±0.96, P=0.025) and apical 2-chamber views (-11.84±0.78 vs -14.43±0.83, P=0.002). In the patients in whom no rejection was identified on either EBM, there was no significant change in longitudinal strain values at two different time points. Worsening of longitudinal strain was associated with acute cellular rejection. Routine TTE-based strain analysis could help in early detection of cardiac rejection and timing of EMB.


  • Echocardiography in coronary artery disease

    by Regina Votavová, Anna Linhartová, Josef Kořínek, Josef Marek, Aleš Linhart

    Coronary artery disease (CAD) is one of the major causes of morbidity and mortality. Imaging techniques represent the key method for disease extent and severity assessment and evaluation of hemodynamic complications. In skilled hands the method provides useful information for clinical management and prognosis assessment. Complex evaluation brings information about global and regional myocardial function, myocardial viability, ischemic mitral regurgitation, and about development of complications such as left ventricular thrombus formation, myocardial rupture and pericardial effusion. The main drawback of echocardiography is the limited echogenicity of many patients and its undeniable operator-dependence. However, the possibility of bringing the echocardiographic imaging to the bedside of our patients makes the method essential and its knowledge indispensable for all cardiologists


  • Arterial Stiffening Contributes to Impairment of Cerebrovascular Reactivity in Patients With Coronary Artery Disease Without Carotid Stenosis

    by D. Rucka, J. Marek, Z. Rucklova, J.-C. Lubanda, S. Havranek, J. Skvaril, P. Varejka, M. Chochola, D. Karetova, J. Korinek, et al.

    Impaired cerebrovascular reactivity (CVR), an important risk factor for future stroke, is affected by a presence carotid stenosis. However, in some cases CVR can be impaired in the absence of carotid stenosis due to several poorly characterized mechanisms. We hypothesized that arterial stiffening as observed in coronary heart disease (CHD) could be associated with alteration in CVR in CHD patients without carotid stenosis. The study population consisted of patients referred for coronary angiography without significant carotid stenosis (<50 %). CVR was evaluated by breath holding index (BHI) measured with transcranial color code duplex ultrasound. Arterial stiffness was assessed by pulse wave velocity (PWV) measured by the oscillometric method. The extent of coronary atherosclerosis was quantified by Gensini score (GS). Out of 186 subjects, sixty-two patients fulfilled the inclusion and exclusion criteria. BHI decreased with increasing PWV (r = –0.47, p<0.001). Decrease in BHI was significantly inversely associated with GS (r = –0.61, p<0.001). GS was associated with PWV (p<0.001). In conclusion, impaired CVR was associated with increased arterial stiffening in CHD patients in the absence of significant carotid stenosis. Thus, we speculate that increased arterial stiffness may at least partially contribute to the pathophysiology of CVR alteration in coronary artery disease.


  • Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Reply to a letter to the authors

    by Martin Balik, Jan Rulisek, Pavel Leden, Michal Zakharchenko, Michal Otahal, Hana Bartakova, Josef Korinek


  • Open Access

    CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart

    by Fernando L. Martin, S. Jeson Sangaralingham, Brenda K. Huntley, Paul M. McKie, Tomoko Ichiki, Horng H. Chen, Josef Korinek, Gerald E. Harders, John C. Burnett

    Natriuretic peptides (NPs) are cardioprotective through the activation of guanylyl cyclase (GC) receptors A and B. CD-NP, also known as cenderitide, is a novel engineered NP that was designed to uniquely serve as a first-in-class dual GC receptor agonist. Recognizing the aldosterone suppressing actions of GC-A activation and the potent inhibitory actions on collagen synthesis and fibroblast proliferation through GC-B activation, the current study was designed to establish the anti-fibrotic actions of CD-NP, administered subcutaneously, in an experimental rat model of early cardiac fibrosis induced by unilateral nephrectomy (UNX). Our results demonstrate that a two week subcutaneous infusion of CD-NP significantly suppresses left ventricular fibrosis and circulating aldosterone, while preserving both systolic and diastolic function, in UNX rats compared to vehicle treated UNX rats. Additionally we also confirmed, in vitro, that CD-NP significantly generates the second messenger, cGMP, through both the GC-A and GC-B receptors. Taken together, this novel dual GC receptor activator may represent an innovative anti-fibrotic therapeutic agent.


  • Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock

    by Martin Balik, Jan Rulisek, Pavel Leden, Michal Zakharchenko, Michal Otahal, Hana Bartakova, Josef Korinek

    Betablockade has been shown to have cardioprotective effects in patients under perioperative stress. Besides animal model of septic shock and a small cohort of septic patients, these benefits have not been studied in septic shock patients who require norepinephrine administration. After correction of preload, an esmolol bolus (0.2–0.5 mg/kg) followed by continuous 24 h infusion was administered in septic patients with sinus or supraventricular tachycardia (HR > 120/min). Exclusion criteria were severe LV systolic dysfunction, atrioventricular blockade and norepinephrine infusion at rates over 0.5 mg/kg/min. Monitoring with echocardiography and pulmonary artery catheter before, at 2, 6, 12, 24 h following the start and 6 h after ceasing of the esmolol drip. Patients were maintained normovolemic throughout the study and adjustments of concomitant norepinephrine infusion rates were made as required. Ten septic patients (mean age 54.4 ± 18.7), APACHE II 21.5 ± 6.2, CRP 275 ± 78 mg/l, procalcitonin 14.5 ± 10.1 mg/l, were given esmolol drip of 212.5 ± 63.5 mg/h at start to 272.5 ± 89.5 mg/h at 24 h. Heart rate decreased from mean 142 ± 11/min to 112 ± 9/min (p < 0.001) with parallel insignificant reduction of cardiac index (4.94 ± 0.76 to 4.35 ± 0.72 l/min/m2). Stroke volume insignificantly increased from 67.1 ± 16.3 ml to 72.9 ± 15.3 ml. No parallel change of pulmonary artery wedge pressure was observed (15.9 ± 3.2 to 15.0 ± 2.4 mmHg) as well as no significant changes of norepinephrine infusion (0.13 ± 0.17 to 0.17 ± 0.19 mg/kg/min), DO2, VO2, OER or arterial lactate. Saving the heart 30 beats/min did not demonstrate adverse impact on global haemodynamics in rates above 110/min. Using well titratable betablocker seems to be safe and cardioprotective in septic shock patients with high cardiac output. Es ist gezeigt worden, dass eine b-Blockade bei Patienten unter perioperativem Stress einen kardioprotektiven Effekt hat. Diese benefiziäre Wirkung wurde bisher auber am Tiermodell des septischen Schocks und an einer kleinen Kohorte von Patienten noch nicht an Patienten mit septischem Schock, die eine Noradrenalin Verabreichung benötigen, gezeigt. Nach Korrektur der Preload wurde ein Esmolol Bolus (0,2–0,5 mg/kg) mit einer nachfolgenden 24 h Dauerinfusion Patienten mit Sepsis und Sinus- oder supraventrikulärer Tachykardie (Herzfrequenz > 120/min) verabreicht. Ausschlusskriterien waren folgende Parameter: schwere Dysfunktion des linken Ventrikels, AV-Blockaden und Noradrenalin Infusionen mit einer Geschwindigkeit über 0,5 mg/kg/min. Die Patienten wurden echokardiographisch und mit Pulmonalarterien Katheter vor und 2, 6, 12, 24 h nach dem Beginn, sowie 6 h nach Ende der Esmolol Infusion überwacht. Die Patienten wurden während der Studie normovolämisch gehalten. Die gleichzeitige Noradrenalin Infusionsrate wurde nach Notwendigkeit adaptiert. Zehn septischen Patienten (mittleres Alter 54,4 ± 18,7, APACHE II 21,5 ± 6,2, CRP 275 ± 78 mg/l, Procalcitonin 14,5 ± 10,1 mg/l) wurde eine Esmolol Infusion (212,5 ± 63,5 mg/h zu Beginn bis 272,5 ± 89,5 mg/h nach 24 h) verabreicht. Die Herzfrequenz sank im Mittel von 142 ± 11/min auf 112 ± 9/min (p < 0,001) parallel zu einer Abnahme des Cardiac Index (4,94 ± 0,76 to 4,35 ± 0,72 l/min/m2). Das Schlagvolumen stieg nicht signifikant von 67,1 ± 16,3 ml auf 72,9 ± 15,3 ml. Es wurde keine parallele Änderung des Pulmonal-arteriellen Wedge Drucks beobachtet (15,9 ± 3,2 auf 15,0 ± 2,4 mmHg). Auch die Infusionsraten der Noradrenalin Infusionen (0,13 ± 0,17 auf 0,17 ± 0,19 mg/kg/min) änderten sich ebenso nicht signifikant wie die DO2, VO2, OER oder das arterielle Laktat. Eine Senkung der Herzrate um 30 Schläge/min bei Herzfrequenzen über 110/min zeigte keine nachteilige Wirkung auf die globale Hämodynamik. Der Einsatz einer gut titrierbaren Betablockade scheint sicher und kardioprotektiv bei Patienten mit septischen Schock und hohem Cardiac Output zu sein.


  • Variable phenotype in murine transverse aortic constriction

    by Selma F. Mohammed, Jimmy R. Storlie, Elise A. Oehler, Lorna A. Bowen, Josef Korinek, Carolyn S.P. Lam, Robert D. Simari, John C. Burnett, Margaret M. Redfield


  • Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection

    by Fernando L. Martin, Paul M. McKie, Alessandro Cataliotti, S. Jeson Sangaralingham, Josef Korinek, Brenda K. Huntley, Elise A. Oehler, Gerald E. Harders, Tomoko Ichiki, Sarah Mangiafico, et al.

    Impaired renal function with loss of nephron number in chronic renal disease (CKD) is associated with increased cardiovascular morbidity and mortality. However, the structural and functional cardiac response to early and mild reduction in renal mass is poorly defined. We hypothesized that mild renal impairment produced by unilateral nephrectomy (UNX) would result in early cardiac fibrosis and impaired diastolic function, which would progress to a more global left ventricular (LV) dysfunction. Cardiorenal function and structure were assessed in rats at 4 and 16 wk following UNX or sham operation (Sham); (n = 10 per group). At 4 wk, blood pressure (BP), aldosterone, glomerular filtration rate (GFR), proteinuria, and plasma B-type natriuretic peptide (BNP) were not altered by UNX, representing a model of mild early CKD. However, UNX was associated with significantly greater LV myocardial fibrosis compared with Sham. Importantly, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining revealed increased apoptosis in the LV myocardium. Further, diastolic dysfunction, assessed by strain echocardiography, but with preserved LVEF, was observed. Changes in genes related to the TGF-β and apoptosis pathways in the LV myocardium were also observed. At 16 wk post-UNX, we observed persistent LV fibrosis and impairment in LV diastolic function. In addition, LV mass significantly increased, as did LVEDd, while there was a reduction in LVEF. Aldosterone, BNP, and proteinuria were increased, while GFR was decreased. The myocardial, structural, and functional alterations were associated with persistent changes in the TGF-β pathway and even more widespread changes in the LV apoptotic pathway. These studies demonstrate that mild renal insufficiency in the rat results in early cardiac fibrosis and impaired diastolic function, which progresses to more global LV remodeling and dysfunction. Thus, these studies importantly advance the concept of a kidney-heart connection in the control of myocardial structure and function.


  • Secondary Prevention Strategies

    by Romero Corral Abel, Lopez Jimenez Francisco, Josef Korinek, Virend Somers, Thomas E. Kottke